Literature DB >> 6715377

Three monoclonal antibodies to rabbit microsomal cytochrome P-450 1 recognize distinct epitopes that are shared to different degrees among other electrophoretic types of cytochrome P-450.

I Reubi, K J Griffin, J L Raucy, E F Johnson.   

Abstract

Three monoclonal antibodies, 1F11, 1G11, and 2F5, were developed toward rabbit microsomal cytochrome P-450 1. Each was linked to Sepharose in order to indirectly immunoprecipitate microsomal proteins. All three antibodies bind polypeptides from solubilized microsomes that exhibit the same electrophoretic mobility as P-450 1. However, 2F5 recognizes an additional microsomal protein that exhibits a relative electrophoretic mobility between that of P-450 1 and 3b that does not appear to be P-450 2. 1G11 also reacts with several microsomal proteins that include both P-450 1 and P-450 3b. These results indicate that at least three electrophoretically distinct forms of microsomal P-450 share one or more antigenic determinants with P-450 1. Binding studies demonstrate that each antibody can react independently with P-450 1, indicating that the three antigenic determinants recognized by the respective monoclonal antibodies are spatially distinct and nonoverlapping. Reconstituted P-450 1 isolated from rabbit liver microsomes that exhibit 10-fold higher progesterone 21-hydroxylase than most preparations of liver microsomes obtained from outbred New Zealand White rabbits catalyzes this reaction with relatively high rates compared to that exhibited by microsomes or to that catalyzed by five electrophoretically distinct forms of P-450. Both the 1F11 and 2F5 antibodies extensively inhibit the liver microsomal 21-hydroxylation of progesterone. When the 1F11 antibody is used to indirectly immunoprecipitate the antigens it recognizes in microsomes displaying a high rate of progesterone 21-hydroxylase activity, a single electrophoretic band corresponding in mobility to P-450 1 was observed.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6715377

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  Hybrid cytochromes P-450 identify a substrate binding domain in P-450IIC5 and P-450IIC4.

Authors:  T Kronbach; T M Larabee; E F Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

2.  Characterization of the steroid-metabolizing capacity of the hepatic cytochrome P450IIC5 expressed in COS-1 cells: 3 beta-hydroxysteroid dehydrogenase/delta 5----4 isomerase type activity.

Authors:  J M Trant; M C Lorence; E F Johnson; C H Shackleton; J I Mason; R W Estabrook
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

3.  Purification of a human liver cytochrome P-450 immunochemically related to several cytochromes P-450 purified from untreated rats.

Authors:  S A Wrighton; P E Thomas; P Willis; S L Maines; P B Watkins; W Levin; P S Guzelian
Journal:  J Clin Invest       Date:  1987-10       Impact factor: 14.808

4.  Epitope-relatedness and phenotyping of hepatic cytochromes P-450 with monoclonal antibodies.

Authors:  B J Song; H V Gelboin; S S Park; F K Friedman
Journal:  Biochem J       Date:  1985-11-01       Impact factor: 3.857

5.  Sex-dependent expression of mouse testosterone 16 alpha-hydroxylase (cytochrome P-450(16) alpha): cDNA cloning and pretranslational regulation.

Authors:  N Harada; M Negishi
Journal:  Proc Natl Acad Sci U S A       Date:  1985-04       Impact factor: 11.205

6.  Cloning and characterization of cDNAs encoding 2,3,7,8-tetrachlorodibenzo-p-dioxin-inducible rabbit mRNAs for cytochrome P-450 isozymes 4 and 6.

Authors:  S T Okino; L C Quattrochi; H J Barnes; S Osanto; K J Griffin; E F Johnson; R H Tukey
Journal:  Proc Natl Acad Sci U S A       Date:  1985-08       Impact factor: 11.205

7.  Cloning of a cDNA coding for P-450 LM3c from rabbit liver microsomes and regulation of its expression.

Authors:  C Dalet; J M Blanchard; P Guzelian; J Barwick; H Hartle; P Maurel
Journal:  Nucleic Acids Res       Date:  1986-08-11       Impact factor: 16.971

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.